European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer

Dirk De Ruysscher, Corinne Faivre-Finn, Ursula Nestle, Coen W. Hurkmans, Cécile Le Péchoux, Allan Price, Suresh Senan

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Purpose: To derive recommendations for routine practice and clinical trials for techniques used in high-dose, high-precision thoracic radiotherapy for lung cancer. Methods: A literature search was performed to identify published articles considered both clinically relevant and practical to use. Recommendations were categorized under the following headings: patient selection, patient positioning and immobilization, tumor motion, computed tomography and [18F]fluorodeoxyglucose - positron emission technology scanning, generating target volumes, radiotherapy treatment planning, treatment delivery, and scoring of response and toxicity. The American College of Chest Physicians grading of recommendations was used. Results: Recommendations were identified for each of the recommendation categories. Although most of the recommended techniques have not been evaluated in multicenter clinical trials, their use in high-precision thoracic radiotherapy and stereotactic body radiotherapy (SBRT) appears to be justified on the basis of available evidence. Conclusion: Recommendations to facilitate the clinical implementation of high-precision conformal radiotherapy and SBRT for lung tumors were identified from the literature. Some techniques that are considered investigational at present were also highlighted. © 2010 by American Society of Clinical Oncology.
    Original languageEnglish
    Pages (from-to)5301-5310
    Number of pages9
    JournalJournal of Clinical Oncology
    Volume28
    Issue number36
    DOIs
    Publication statusPublished - 20 Dec 2010

    Fingerprint

    Dive into the research topics of 'European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer'. Together they form a unique fingerprint.

    Cite this